Optineurin
Optineurin is a protein encoded by the OPTN gene in humans. It is involved in various cellular processes, including vesicle trafficking, inflammation, and autophagy. Optineurin has been implicated in several diseases, most notably glaucoma and amyotrophic lateral sclerosis (ALS).
Structure
Optineurin is a 577 amino acid protein with a molecular weight of approximately 66 kDa. It contains several functional domains, including a coiled-coil domain, a zinc finger domain, and a ubiquitin-binding domain. These domains facilitate its interactions with other proteins and its involvement in cellular pathways.
Function
Optineurin plays a critical role in maintaining cellular homeostasis. It is involved in:
- Vesicle Trafficking: Optineurin interacts with Rab8, a small GTPase, to regulate the trafficking of vesicles from the Golgi apparatus to the plasma membrane.
- Inflammation: It acts as a negative regulator of the NF-kB signaling pathway, thereby modulating inflammatory responses.
- Autophagy: Optineurin is involved in the selective autophagy of damaged mitochondria, a process known as mitophagy. It interacts with the autophagy receptor LC3 to facilitate the clearance of damaged organelles.
Clinical Significance
Mutations in the OPTN gene have been associated with several diseases:
- Glaucoma: Certain mutations in OPTN are linked to normal-tension glaucoma, a condition characterized by damage to the optic nerve despite normal intraocular pressure.
- Amyotrophic Lateral Sclerosis (ALS): Mutations in OPTN have been identified in patients with ALS, a neurodegenerative disease affecting motor neurons.
- Paget's Disease of Bone: Some studies suggest a potential link between OPTN mutations and Paget's disease, although the evidence is less conclusive.
Research Directions
Ongoing research is focused on understanding the precise molecular mechanisms by which optineurin mutations lead to disease. There is also interest in exploring optineurin as a potential therapeutic target for conditions like glaucoma and ALS.
Also see
Ad. Transform your life with W8MD's Budget GLP-1 injections from $75


W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Weight loss injections in NYC (generic and brand names):
- Zepbound / Mounjaro, Wegovy / Ozempic, Saxenda
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $75 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointmentsNYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
